• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Former Corindus CEO Toland joins robotic `micro’ surgical startup

Former Corindus CEO Toland joins robotic `micro’ surgical startup

January 12, 2021 By Tom Salemi Leave a Comment

Mark Toland, the former CEO of Corindus Vascular Robotics, believes the next big opportunity for surgical robotics is actually very small.

Toland, who sold the telesurgery robotics company to Siemens in 2019 for $1.1 billion, is now the CEO of Medical Microinstruments S.p.A. (MMI), an Italian company that has developed a surgical robotic system capable of performing microsurgery on capillaries, small vessels and other parts of the body existing robots – and maybe even surgeons – can’t reach.

“You see robotics companies that are trying to be the next Intuitive surgical or go after the laparoscopic surgery play,” Toland says. The objective “of this company is, `I want to create a field that doesn’t even exist today.’”

Founded in 2015 near Pisa, MMI in 2019 secured a CE-Mark for its Symani Surgical System to be used in open microsurgical procedures. The system already has been used in four surgical procedures in Florence, Italy including three post-traumatic lower limb reconstructions as well as a post-oncological reconstruction of the pharynx.

In an interview with the DeviceTalks Weekly Podcast to be published on Friday, Toland explains how MMI’s NanoWrist microinstruments offer better precision and range of movement than other robotic systems.

Toland says Symanni’s system can scale down a surgeons movement 20 times, making smaller, more precise movements possible. MMI’s NanoWrist design also allows for seven degrees of freedom, acting more like a surgeon’s own wrist. “The current robots on the market today have between three to five degrees of freedom,” Toland said.

Toland says the increased abilities of the robots could enable Symanni to do “things we’ve never been able to do in healthcare before.”

The company’s immediate plans center around collecting data on a limited rollout in Europe. Then, it could be in position to apply for FDA approval in 2021.

In a press release, MMI Chairman Andrew Cleeland, the one-time CEO of innovative start-ups Ardian and Twelve, pointed to Toland’s experience in the robotics field as  boon for the company. “We look forward to empowering surgeons around the world with the most advanced technology that will make highly complex procedures more reproducible and new procedures possible,” he stated.

In 2020, MMI signed a financing agreement with the EU providing it up to €15 million ($17.74 million) to be deployed over the coming years to support its long-term financial strategy. MMI previously announced raising a €20 million Series A in 2018 from Andera Partners, Panakes Partners, Fountain Healthcare Partners and Sambatech.

Founders of the company include Giuseppe Prisco, PhD, the previous CEO and a former managing principal and engineer at Intuitive Surgical, Massimiliano Simi, PhD, investor of MMI’s NanoWrist articulated microinstruments, and Hannah Teichmann, PhD., now vice president of clinical development who is leading the effort to validate the surgical system.

In addition to his role at MMI, Toland remains involved in the venture fund, BioStar Capital. To hear his wide thoughts on the future or robotics as well as his plans at BioStar, susbcribe to the DeviceTalks Weekly Podcast on Apple Podcasts, Spotify and other podcast platforms.

 

Filed Under: Device Talks Podcasts, Featured, Robotics, Surgical Tagged With: Ardian, BioStar Capital, Corindus Vascular Robotics, Medical Microinstruments, Siemens, Siemens Healthineers, Twelve

In case you missed it

  • These medtech stocks performed the best in 2020
  • Medtronic launches deep brain stim trial for Parkinson’s disease
  • Former FDA commissioner Kessler to help lead Biden’s COVID-19 response
  • Facial swelling and COVID-19 vaccines: 4 facts
  • Here’s what molecular shape can tell you about pharma innovation
  • Norway investigating deaths of 23 individuals who received COVID-19 vaccine
  • 3M, Honeywell gain antitrust protection to boost N95 mask supply
  • Leading Medical UX Trends
  • Ex-Acclarent execs fined $1.5M in off-label marketing case
  • Former CDER head Woodcock to lead FDA for now
  • Prosecutors want to present evidence of Elizabeth Holmes’ quest for wealth and fame
  • TransEnterix raises more than $31M in stock offering
  • Boston Scientific launches WaveWriter Alpha spinal cord stim
  • What’s next for the FDA and for Stephen Hahn?
  • Apple magnetic charger, smartwatch may deactivate Medtronic ICD
  • Medicare to cover breakthrough devices
  • FDA debuts plan for AI-based Software as a Medical Device

RSS From Medical Design & Outsourcing

  • These medtech stocks performed the best in 2020
    While 2020 did not go as planned for anyone, with the twists and turns came opportunities for medtech companies to power forward. Innovations came both as a result of the COVID-19 pandemic and perhaps in spite of the challenges brought on by the virus, highlighted by the increased efforts to produce vaccines and testing while… […]
  • Covestro tests plastics against high-strength hospital disinfectants
    Covestro announced that it recently teamed with disinfectant manufacturer Metrex to test six different Covestro polycarbonate materials against three of Metrex’s products, which are widely used throughout the healthcare industry. As is customary for rapidly assessing the compatibility of plastics to disinfectants, test specimens were pre-strained and underwent several wipe-and-dry cycles with Metrex disinfectants to… […]
  • Integer expands N.Y. battery plant
    Integer announced today that it recently broke ground on an expansion of its Alden, N.Y., facility to accommodate new equipment that will substantially increase the plant’s production capacity for rechargeable Xcellion lithium-ion batteries. The project kicked off in mid-December 2020 and will add both production equipment and a build-out of Integer’s existing facility. The company… […]
  • Diversified Plastics adds high-efficiency vertical presses
    Diversified Plastics (DPI) announced that it recently installed six all-electric vertical injection molding presses. These presses will join DPI’s existing assemblage of vertical presses and provide increased production capacity to meet growing demand from medical device and other original equipment manufacturers (OEMs). DPI uses vertical presses for over-molding and insert-molding, capabilities often required for medical… […]
  • Traco Power expands power supply line for portable medical equipment
    Traco Power announced that it has expanded its TPP 450 high-density 3×5 power supply series. The series now offers Protection Class II models (TPP 450BA-M Open-Frame Models and TPP 450B-M Enclosed with Fan Models), designed for non-stationary requirements where connection to ground is not possible. Key approvals on the original series remain on the expanded… […]
  • Reflow Medical launches low-profile reinforced support catheters
    Reflow Medical today announced it has launched its Reflow Spex Low Profile reinforced support catheters. The Spex LP catheters are designed to provide the lowest profile tip to access and cross the tightest and most complex lesions with a supportive system. They come in 0.014 in. and 0.018 in. sizes and can be combined with… […]
  • Former CDER head Woodcock to lead FDA for now
    FDA veteran Dr. Janet Woodcock has been tapped as interim FDA commissioner by the Biden administration, according to published reports. An article by BioCentury also said that former FDA commissioner David Kessler, who had been mentioned as a possible replacement for current commissioner Stephen Hahn, will be a consultant to the agency but will not… […]
  • What’s next for the FDA and for Stephen Hahn?
    Outgoing FDA commissioner Stephen Hahn says he needs some time to reflect on his future after leading the FDA for a little over a year. It’s hard to blame him. Hahn’s brief tenure at FDA has been rocky, to say the least. (News of his temporary replacement broke on Thursday, when the incoming Biden administration… […]
  • Medicare to cover breakthrough devices
    FDA-designated breakthrough devices will have Medicare coverage the same day they are approved, under a final rule issued this week by the Centers for Medicare and Medicaid Services (CMS). The Medicare Coverage of Innovative Technology (MCIT) rule will provide national Medicare coverage as early as the same day as FDA market authorization for breakthrough devices… […]
  • FDA debuts plan for AI-based Software as a Medical Device
    The FDA today released its first plan to regulate artificial intelligence/machine learning (AI/ML)-based Software as a Medical Device (SaMD). The plan is a response to feedback received from the agency’s April 2019 discussion paper, “Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning-Based Software as a Medical Device.” It outlines five actions that the FDA… […]
  • EU allows remote audits for medical devices during pandemic
    The European Union has announced that it will temporarily allow remote audits of medical devices and in vitro diagnostics under the new regulations (MDR IVDR), set to go into effect on May 2021 and 2022 respectively. In a document published Monday, the European Commission agreed with industry and notified bodies that the ongoing COVID-19 pandemic… […]

Reader Interactions

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS